https://www.businesswire.com/news/home/20200528005424/en/LabCorp-Accelerates-Adoption-Decentralized-Clinical-Trials-Expands
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate …
Create an account or login to join the discussion